AbbVie Completes Acquisition of ImmunoGen
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| AbbVie (NYSE: ABBV) | Delayed: 294.89 +4.10 (1.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $290.79 | 52 Week High | $68.12 | |||
| Open | $292.00 | 52 Week Low | $50.71 | |||
| Day High | $298.74 | P/E | 63.97 | |||
| Day Low | $291.01 | EPS | $4.61 | |||
| Volume | 6,898,158 | |||||
| Immunogen, Inc. (NASDAQ: IMGN) | Delayed: 31.25 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $31.25 | 52 Week High | $14.22 | |||
| Open | $240.83 | 52 Week Low | $1.51 | |||
| Day High | $31.25 | P/E | N/A | |||
| Day Low | $31.25 | EPS | $-0.36 | |||
| Volume | 670,938 | |||||
